New Drugs for an Old Foe: Mycobacterium tuberculosis Meets PSC-Derived Macrophages

Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb...

Descripción completa

Detalles Bibliográficos
Autores principales: Haake, Kathrin, Lachmann, Nico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Preview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915800/
https://www.ncbi.nlm.nih.gov/pubmed/31951563
http://dx.doi.org/10.1016/j.stemcr.2019.11.006
Descripción
Sumario:Infections with Mycobacterium tuberculosis (Mtb) are still among the top 10 causes of death worldwide, highlighting the utmost need for new forms of medical treatments. In this issue of Stem Cell Reports, Han et al. (2019) describe a technique to screen therapeutically active compounds targeting Mtb using pluripotent stem cell-derived macrophages.

Ejemplares similares